25 XP   0   0   10

SUVEN LIFE SCIENCES LTD.
Buy, Hold or Sell?

Let's analyse Suven together

PenkeI guess you are interested in SUVEN LIFE SCIENCES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SUVEN LIFE SCIENCES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SUVEN LIFE SCIENCES LTD.

I send you an email if I find something interesting about SUVEN LIFE SCIENCES LTD..

Quick analysis of Suven (30 sec.)










What can you expect buying and holding a share of Suven? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
INR17.21
Expected worth in 1 year
INR68.42
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
INR51.21
Return On Investment
51.5%

For what price can you sell your share?

Current Price per Share
INR99.40
Expected price per share
INR88.86 - INR121.50
How sure are you?
50%

1. Valuation of Suven (5 min.)




Live pricePrice per Share (EOD)

INR99.40

Intrinsic Value Per Share

INR-86.93 - INR15.44

Total Value Per Share

INR-69.72 - INR32.65

2. Growth of Suven (5 min.)




Is Suven growing?

Current yearPrevious yearGrowGrow %
How rich?$45m$11.5m$33.5m74.4%

How much money is Suven making?

Current yearPrevious yearGrowGrow %
Making money-$14.1m-$14.6m$447.2k3.2%
Net Profit Margin-873.5%-1,030.0%--

How much money comes from the company's main activities?

3. Financial Health of Suven (5 min.)




What can you expect buying and holding a share of Suven? (5 min.)

Welcome investor! Suven's management wants to use your money to grow the business. In return you get a share of Suven.

What can you expect buying and holding a share of Suven?

First you should know what it really means to hold a share of Suven. And how you can make/lose money.

Speculation

The Price per Share of Suven is INR99.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Suven.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Suven, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR17.21. Based on the TTM, the Book Value Change Per Share is INR12.80 per quarter. Based on the YOY, the Book Value Change Per Share is INR-0.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Suven.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.07-0.1%-0.07-0.1%-0.07-0.1%-0.050.0%0.010.0%
Usd Book Value Change Per Share0.150.2%0.150.2%-0.010.0%-0.040.0%0.020.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.0%
Usd Total Gains Per Share0.150.2%0.150.2%-0.010.0%-0.040.0%0.030.0%
Usd Price Per Share0.58-0.58-1.11-1.19-1.66-
Price to Earnings Ratio-8.94--8.94--16.58--57.95--9.15-
Price-to-Total Gains Ratio3.79-3.79--170.54--45.26--7.25-
Price to Book Ratio2.82-2.82-21.04-13.02-9.95-
Price-to-Total Gains Ratio3.79-3.79--170.54--45.26--7.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1928
Number of shares838
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.15-0.04
Usd Total Gains Per Share0.15-0.04
Gains per Quarter (838 shares)128.73-34.04
Gains per Year (838 shares)514.94-136.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105155058-145-146
201030102017-289-282
301545153525-434-418
402060205034-579-554
502575256542-723-690
603090308051-868-826
703605359559-1012-962
804120411068-1157-1098
904634462576-1302-1234
1005149514085-1446-1370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%5.05.00.050.0%5.05.00.050.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%6.00.04.060.0%6.00.04.060.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%6.04.00.060.0%6.04.00.060.0%

Fundamentals of Suven

About SUVEN LIFE SCIENCES LTD.

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a potent and selective histamine H3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), a novel, potent, and selective a4ß2 nicotinic acetylcholine receptor antagonist for the treatment of depressive disorders. The company is also developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

Fundamental data was last updated by Penke on 2024-03-13 05:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of SUVEN LIFE SCIENCES LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Suven earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -873.5% means that ₹-8.74 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is -873.5%. The company is making a huge loss. -2
  • The TTM is -873.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-873.5%TTM-873.5%0.0%
TTM-873.5%YOY-1,030.0%+156.5%
TTM-873.5%5Y-620.2%-253.4%
5Y-620.2%10Y-300.2%-320.0%
1.1.2. Return on Assets

Shows how efficient Suven is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • -30.4% Return on Assets means that Suven generated ₹-0.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is -30.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -30.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.4%TTM-30.4%0.0%
TTM-30.4%YOY-112.9%+82.5%
TTM-30.4%5Y-51.8%+21.4%
5Y-51.8%10Y-18.2%-33.7%
1.1.3. Return on Equity

Shows how efficient Suven is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • -31.5% Return on Equity means Suven generated ₹-0.32 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is -31.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -31.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.5%TTM-31.5%0.0%
TTM-31.5%YOY-126.9%+95.4%
TTM-31.5%5Y-60.2%+28.7%
5Y-60.2%10Y-18.6%-41.6%

1.2. Operating Efficiency of SUVEN LIFE SCIENCES LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Suven is operating .

  • Measures how much profit Suven makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -978.1% means the company generated ₹-9.78  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is -978.1%. The company is operating very inefficient. -2
  • The TTM is -978.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-978.1%TTM-978.1%0.0%
TTM-978.1%YOY-1,065.6%+87.5%
TTM-978.1%5Y-701.5%-276.6%
5Y-701.5%10Y-337.3%-364.2%
1.2.2. Operating Ratio

Measures how efficient Suven is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 10.81 means that the operating costs are ₹10.81 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is 10.808. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.808. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.808TTM10.8080.000
TTM10.808YOY11.658-0.850
TTM10.8085Y8.238+2.570
5Y8.23810Y4.686+3.552

1.3. Liquidity of SUVEN LIFE SCIENCES LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Suven is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 22.61 means the company has ₹22.61 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is 22.605. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.605. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ22.605TTM22.6050.000
TTM22.605YOY8.009+14.596
TTM22.6055Y9.326+13.279
5Y9.32610Y6.488+2.838
1.3.2. Quick Ratio

Measures if Suven is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 37.80 means the company can pay off ₹37.80 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is 37.795. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 37.795. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ37.795TTM37.7950.000
TTM37.795YOY11.654+26.142
TTM37.7955Y13.171+24.624
5Y13.17110Y8.104+5.068

1.4. Solvency of SUVEN LIFE SCIENCES LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Suven assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Suven to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.03 means that Suven assets are financed with 3.5% credit (debt) and the remaining percentage (100% - 3.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is 0.035. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.035. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.035TTM0.0350.000
TTM0.035YOY0.110-0.075
TTM0.0355Y0.146-0.111
5Y0.14610Y0.202-0.056
1.4.2. Debt to Equity Ratio

Measures if Suven is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 3.6% means that company has ₹0.04 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The MRQ is 0.036. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.036. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.036TTM0.0360.000
TTM0.036YOY0.124-0.087
TTM0.0365Y0.177-0.141
5Y0.17710Y0.279-0.102

2. Market Valuation of SUVEN LIFE SCIENCES LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Suven generates.

  • Above 15 is considered overpriced but always compare Suven to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -8.94 means the investor is paying ₹-8.94 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The EOD is -18.328. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.937. Based on the earnings, the company is expensive. -2
  • The TTM is -8.937. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.328MRQ-8.937-9.391
MRQ-8.937TTM-8.9370.000
TTM-8.937YOY-16.580+7.642
TTM-8.9375Y-57.953+49.015
5Y-57.95310Y-9.154-48.799
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The EOD is -20.441. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.968. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.968. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.441MRQ-9.968-10.474
MRQ-9.968TTM-9.9680.000
TTM-9.968YOY-13.731+3.763
TTM-9.9685Y-26.566+16.599
5Y-26.56610Y75.325-101.891
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Suven is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.82 means the investor is paying ₹2.82 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of SUVEN LIFE SCIENCES LTD.:

  • The EOD is 5.775. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.816. Based on the equity, the company is underpriced. +1
  • The TTM is 2.816. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.775MRQ2.816+2.959
MRQ2.816TTM2.8160.000
TTM2.816YOY21.037-18.221
TTM2.8165Y13.023-10.207
5Y13.02310Y9.953+3.070
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SUVEN LIFE SCIENCES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--12.80212.8020%-0.544+104%-3.596+128%1.721+644%
Book Value Per Share--17.21117.2110%4.409+290%8.822+95%17.496-2%
Current Ratio--22.60522.6050%8.009+182%9.326+142%6.488+248%
Debt To Asset Ratio--0.0350.0350%0.110-68%0.146-76%0.202-83%
Debt To Equity Ratio--0.0360.0360%0.124-71%0.177-80%0.279-87%
Dividend Per Share----0%-0%0.211-100%0.610-100%
Eps---5.423-5.4230%-5.594+3%-3.949-27%0.482-1225%
Free Cash Flow Per Share---4.863-4.8630%-6.755+39%-5.630+16%-1.782-63%
Free Cash Flow To Equity Per Share--13.27513.2750%-0.074+101%-0.280+102%0.849+1463%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--15.436--------
Intrinsic Value_10Y_min---86.928--------
Intrinsic Value_1Y_max---3.940--------
Intrinsic Value_1Y_min---6.473--------
Intrinsic Value_3Y_max---7.656--------
Intrinsic Value_3Y_min---21.501--------
Intrinsic Value_5Y_max---6.332--------
Intrinsic Value_5Y_min---38.666--------
Market Cap21676555600.000+51%10570046780.00010570046780.0000%20226363500.000-48%21542222016.000-51%30102280738.000-65%
Net Profit Margin---8.735-8.7350%-10.300+18%-6.202-29%-3.002-66%
Operating Margin---9.781-9.7810%-10.656+9%-7.015-28%-3.373-66%
Operating Ratio--10.80810.8080%11.658-7%8.238+31%4.686+131%
Pb Ratio5.775+51%2.8162.8160%21.037-87%13.023-78%9.953-72%
Pe Ratio-18.328-105%-8.937-8.9370%-16.580+86%-57.953+548%-9.154+2%
Price Per Share99.400+51%48.47048.4700%92.750-48%98.784-51%138.037-65%
Price To Free Cash Flow Ratio-20.441-105%-9.968-9.9680%-13.731+38%-26.566+167%75.325-113%
Price To Total Gains Ratio7.765+51%3.7863.7860%-170.538+4604%-45.265+1296%-7.251+292%
Quick Ratio--37.79537.7950%11.654+224%13.171+187%8.104+366%
Return On Assets---0.304-0.3040%-1.129+271%-0.518+70%-0.182-40%
Return On Equity---0.315-0.3150%-1.269+303%-0.602+91%-0.186-41%
Total Gains Per Share--12.80212.8020%-0.544+104%-3.385+126%2.331+449%
Usd Book Value--45038316.00045038316.0000%11537436.000+290%23086761.600+95%45784786.800-2%
Usd Book Value Change Per Share--0.1540.1540%-0.007+104%-0.043+128%0.021+644%
Usd Book Value Per Share--0.2070.2070%0.053+290%0.106+95%0.210-2%
Usd Dividend Per Share----0%-0%0.003-100%0.007-100%
Usd Eps---0.065-0.0650%-0.067+3%-0.047-27%0.006-1225%
Usd Free Cash Flow---12725160.000-12725160.0000%-17677032.000+39%-14734075.200+16%-4662892.800-63%
Usd Free Cash Flow Per Share---0.058-0.0580%-0.081+39%-0.068+16%-0.021-63%
Usd Free Cash Flow To Equity Per Share--0.1590.1590%-0.001+101%-0.003+102%0.010+1463%
Usd Market Cap260118667.200+51%126840561.360126840561.3600%242716362.000-48%258506664.192-51%361227368.856-65%
Usd Price Per Share1.193+51%0.5820.5820%1.113-48%1.185-51%1.656-65%
Usd Profit---14192136.000-14192136.0000%-14639412.000+3%-10332866.400-27%1261141.200-1225%
Usd Revenue--1624704.0001624704.0000%1421316.000+14%8134708.800-80%36481579.200-96%
Usd Total Gains Per Share--0.1540.1540%-0.007+104%-0.041+126%0.028+449%
 EOD+6 -2MRQTTM+0 -0YOY+28 -55Y+21 -1410Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of SUVEN LIFE SCIENCES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-18.328
Price to Book Ratio (EOD)Between0-15.775
Net Profit Margin (MRQ)Greater than0-8.735
Operating Margin (MRQ)Greater than0-9.781
Quick Ratio (MRQ)Greater than137.795
Current Ratio (MRQ)Greater than122.605
Debt to Asset Ratio (MRQ)Less than10.035
Debt to Equity Ratio (MRQ)Less than10.036
Return on Equity (MRQ)Greater than0.15-0.315
Return on Assets (MRQ)Greater than0.05-0.304
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of SUVEN LIFE SCIENCES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.954
Ma 20Greater thanMa 50102.655
Ma 50Greater thanMa 100106.986
Ma 100Greater thanMa 20096.864
OpenGreater thanClose98.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,889,106
Total Liabilities135,913
Total Stockholder Equity3,753,193
 As reported
Total Liabilities 135,913
Total Stockholder Equity+ 3,753,193
Total Assets = 3,889,106

Assets

Total Assets3,889,106
Total Current Assets2,515,865
Long-term Assets1,373,241
Total Current Assets
Cash And Cash Equivalents 120,191
Short-term Investments 1,914,099
Net Receivables 8,074
Other Current Assets 153,927
Total Current Assets  (as reported)2,515,865
Total Current Assets  (calculated)2,196,291
+/- 319,574
Long-term Assets
Property Plant Equipment 370,161
Intangible Assets 1,981
Other Assets 949
Long-term Assets  (as reported)1,373,241
Long-term Assets  (calculated)373,091
+/- 1,000,150

Liabilities & Shareholders' Equity

Total Current Liabilities111,296
Long-term Liabilities24,617
Total Stockholder Equity3,753,193
Total Current Liabilities
Accounts payable 16,648
Other Current Liabilities 5,453
Total Current Liabilities  (as reported)111,296
Total Current Liabilities  (calculated)22,101
+/- 89,195
Long-term Liabilities
Long term Debt Total 5,792
Capital Lease Obligations Min Short Term Debt16,052
Long-term Liabilities  (as reported)24,617
Long-term Liabilities  (calculated)21,844
+/- 2,773
Total Stockholder Equity
Common Stock218,074
Retained Earnings -2,913,710
Capital Surplus 6,467,820
Other Stockholders Equity -18,991
Total Stockholder Equity (as reported)3,753,193
Total Stockholder Equity (calculated)3,753,193
+/-0
Other
Capital Stock218,074
Cash And Equivalents250,001
Cash and Short Term Investments 2,284,291
Common Stock Shares Outstanding 218,074
Liabilities and Stockholders Equity 3,889,106
Net Invested Capital 3,753,193
Net Working Capital 2,404,569
Property Plant and Equipment Gross 370,161



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
4,866,272
7,731,341
7,514,929
8,157,093
9,191,594
3,033,574
1,819,324
1,284,180
1,080,346
3,889,106
3,889,1061,080,3461,284,1801,819,3243,033,5749,191,5948,157,0937,514,9297,731,3414,866,272
   > Total Current Assets 
2,805,633
4,769,788
4,277,311
4,917,140
5,695,542
2,809,891
659,862
1,026,814
665,945
2,515,865
2,515,865665,9451,026,814659,8622,809,8915,695,5424,917,1404,277,3114,769,7882,805,633
       Cash And Cash Equivalents 
680,284
2,796,890
2,300,616
91,701
112,691
130,074
146,757
93,482
52,736
120,191
120,19152,73693,482146,757130,074112,69191,7012,300,6162,796,890680,284
       Short-term Investments 
364
364
531
3,008,891
2,787,256
2,299,892
494
857
451,620
1,914,099
1,914,099451,6208574942,299,8922,787,2563,008,891531364364
       Net Receivables 
787,163
753,731
535,649
685,406
1,073,386
527,245
22,705
17,619
12,979
8,074
8,07412,97917,61922,705527,2451,073,386685,406535,649753,731787,163
       Inventory 
786,287
818,055
834,644
938,115
1,468,827
2,357
2,899
1,415
330
0
03301,4152,8992,3571,468,827938,115834,644818,055786,287
       Other Current Assets 
542,183
379,467
8,757
167,500
44,420
46,758
53,208
125,942
68,700
153,927
153,92768,700125,94253,20846,75844,420167,5008,757379,467542,183
   > Long-term Assets 
0
0
0
3,239,952
3,512,983
4,156,692
1,159,461
257,366
414,401
1,373,241
1,373,241414,401257,3661,159,4614,156,6923,512,9833,239,952000
       Property Plant Equipment 
1,920,540
2,787,664
3,122,537
3,141,921
3,296,863
223,682
245,424
256,006
408,905
370,161
370,161408,905256,006245,424223,6823,296,8633,141,9213,122,5372,787,6641,920,540
       Long Term Investments 
15
0
705
705
0
0
0
0
0
0
000000705705015
       Intangible Assets 
0
1,961
2,970
12,483
27,831
26,850
1,513
1,360
2,246
1,981
1,9812,2461,3601,51326,85027,83112,4832,9701,9610
       Long-term Assets Other 
0
0
0
7,162
0
1
-1
0
3,250
949
9493,2500-1107,162000
> Total Liabilities 
2,221,809
2,138,200
1,562,081
1,487,105
1,517,529
642,276
385,840
204,124
118,893
135,913
135,913118,893204,124385,840642,2761,517,5291,487,1051,562,0812,138,2002,221,809
   > Total Current Liabilities 
1,550,615
1,273,860
1,106,926
1,186,051
1,215,565
397,208
265,111
159,096
83,147
111,296
111,29683,147159,096265,111397,2081,215,5651,186,0511,106,9261,273,8601,550,615
       Short-term Debt 
905,697
1,085,134
241,637
304,852
305,740
353,024
0
0
0
0
0000353,024305,740304,852241,6371,085,134905,697
       Short Long Term Debt 
905,697
1,085,134
825,567
707,832
261,343
362,364
9,440
9,440
4,843
0
04,8439,4409,440362,364261,343707,832825,5671,085,134905,697
       Accounts payable 
409,005
438,908
356,049
379,397
568,158
70,859
57,820
29,956
19,866
16,648
16,64819,86629,95657,82070,859568,158379,397356,049438,908409,005
       Other Current Liabilities 
375,156
187,921
104,495
102,313
108,086
7,822
7,171
110,295
6,737
5,453
5,4536,737110,2957,1717,822108,086102,313104,495187,921375,156
   > Long-term Liabilities 
0
0
0
301,055
293,567
588,849
120,729
45,028
35,746
24,617
24,61735,74645,028120,729588,849293,567301,055000
       Long term Debt Total 
0
0
416,385
259,322
22,249
17,754
40,199
27,185
15,730
5,792
5,79215,73027,18540,19917,75422,249259,322416,38500
       Capital Lease Obligations 
0
0
0
0
0
0
39,837
34,271
27,243
16,052
16,05227,24334,27139,837000000
       Long-term Liabilities Other 
0
0
0
13,383
10,475
7,570
4,663
556
-1
-1
-1-15564,6637,57010,47513,383000
       Deferred Long Term Liability 
0
48,468
0
0
0
0
0
0
0
0
0000000048,4680
> Total Stockholder Equity
2,644,463
5,593,141
5,952,848
6,669,988
7,674,065
2,391,298
1,433,484
1,080,056
961,453
3,753,193
3,753,193961,4531,080,0561,433,4842,391,2987,674,0656,669,9885,952,8485,593,1412,644,463
   Common Stock
116,829
127,283
127,282
127,282
127,282
127,282
127,282
127,282
145,382
218,074
218,074145,382127,282127,282127,282127,282127,282127,282127,283116,829
   Retained Earnings 
2,125,426
3,074,104
3,493,961
4,212,639
5,215,973
1,158,238
213,105
-511,474
-1,732,930
-2,913,710
-2,913,710-1,732,930-511,474213,1051,158,2385,215,9734,212,6393,493,9613,074,1042,125,426
   Capital Surplus 
0
0
2,331,169
2,331,169
2,331,169
1,108,149
1,108,149
1,108,149
2,566,466
6,467,820
6,467,8202,566,4661,108,1491,108,1491,108,1492,331,1692,331,1692,331,16900
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
436
-1,102
-359
-2,371
-15,052
952,774
-17,464
-18,991
-18,991-17,464952,774-15,052-2,371-359-1,10243600



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue135,392
Cost of Revenue-3,678
Gross Profit131,714131,714
 
Operating Income (+$)
Gross Profit131,714
Operating Expense-1,459,669
Operating Income-1,259,713-1,327,955
 
Operating Expense (+$)
Research Development1,153,510
Selling General Administrative232,485
Selling And Marketing Expenses0
Operating Expense1,459,6691,385,995
 
Net Interest Income (+$)
Interest Income75,906
Interest Expense-2,891
Other Finance Cost-75,906
Net Interest Income-2,891
 
Pretax Income (+$)
Operating Income-1,259,713
Net Interest Income-2,891
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,182,678-1,259,713
EBIT - interestExpense = -1,327,168
-1,182,678
-1,179,787
Interest Expense2,891
Earnings Before Interest and Taxes (EBIT)-1,324,277-1,179,787
Earnings Before Interest and Taxes (EBITDA)-1,114,355
 
After tax Income (+$)
Income Before Tax-1,182,678
Tax Provision-0
Net Income From Continuing Ops-1,182,678-1,182,678
Net Income-1,182,678
Net Income Applicable To Common Shares-1,182,678
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,891
 

Technical Analysis of Suven
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Suven. The general trend of Suven is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Suven's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SUVEN LIFE SCIENCES LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 106.50 < 114.00 < 121.50.

The bearish price targets are: 94.00 > 93.76 > 88.86.

Tweet this
SUVEN LIFE SCIENCES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SUVEN LIFE SCIENCES LTD.. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SUVEN LIFE SCIENCES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SUVEN LIFE SCIENCES LTD.. The current macd is -1.88973464.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Suven price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Suven. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Suven price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
SUVEN LIFE SCIENCES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartSUVEN LIFE SCIENCES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SUVEN LIFE SCIENCES LTD.. The current adx is 11.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Suven shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
SUVEN LIFE SCIENCES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SUVEN LIFE SCIENCES LTD.. The current sar is 103.73.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
SUVEN LIFE SCIENCES LTD. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SUVEN LIFE SCIENCES LTD.. The current rsi is 42.95. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
SUVEN LIFE SCIENCES LTD. Daily Relative Strength Index (RSI) ChartSUVEN LIFE SCIENCES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SUVEN LIFE SCIENCES LTD.. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Suven price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
SUVEN LIFE SCIENCES LTD. Daily Stochastic Oscillator ChartSUVEN LIFE SCIENCES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SUVEN LIFE SCIENCES LTD.. The current cci is -71.64320408.

SUVEN LIFE SCIENCES LTD. Daily Commodity Channel Index (CCI) ChartSUVEN LIFE SCIENCES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SUVEN LIFE SCIENCES LTD.. The current cmo is -18.06147871.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
SUVEN LIFE SCIENCES LTD. Daily Chande Momentum Oscillator (CMO) ChartSUVEN LIFE SCIENCES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SUVEN LIFE SCIENCES LTD.. The current willr is -61.42857143.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Suven is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
SUVEN LIFE SCIENCES LTD. Daily Williams %R ChartSUVEN LIFE SCIENCES LTD. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SUVEN LIFE SCIENCES LTD..

SUVEN LIFE SCIENCES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SUVEN LIFE SCIENCES LTD.. The current atr is 5.06202875.

SUVEN LIFE SCIENCES LTD. Daily Average True Range (ATR) ChartSUVEN LIFE SCIENCES LTD. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SUVEN LIFE SCIENCES LTD.. The current obv is 5,201,465.

SUVEN LIFE SCIENCES LTD. Daily On-Balance Volume (OBV) ChartSUVEN LIFE SCIENCES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SUVEN LIFE SCIENCES LTD.. The current mfi is 22.19.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
SUVEN LIFE SCIENCES LTD. Daily Money Flow Index (MFI) ChartSUVEN LIFE SCIENCES LTD. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SUVEN LIFE SCIENCES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

SUVEN LIFE SCIENCES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SUVEN LIFE SCIENCES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.954
Ma 20Greater thanMa 50102.655
Ma 50Greater thanMa 100106.986
Ma 100Greater thanMa 20096.864
OpenGreater thanClose98.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Suven with someone you think should read this too:
  • Are you bullish or bearish on Suven? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Suven? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SUVEN LIFE SCIENCES LTD.

I send you an email if I find something interesting about SUVEN LIFE SCIENCES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about SUVEN LIFE SCIENCES LTD..

Receive notifications about SUVEN LIFE SCIENCES LTD. in your mailbox!